All News

burnout work overworked

High Burnout Rates Among Rheumatologists

Jack Cush, MD
Oct 22, 2020

Bergman and colleagues have studied a large cohort of US rheumatologists and found that nearly half meet at least one criterion defining "burnout" among physicians.

Read Article
COVID.virus_.corona_1.jpg

Remdesivir FDA Approved for Hospitalized COVID-19

Jack Cush, MD
Oct 22, 2020

The FDA has approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.

Read Article
FDA approved its 1st drug to treat COVID-19 - the antiviral drug Veklury (remdesivir) for for acute care treatment of COVID-19 requiring hospitalization. Approval based on 3 clinical trials showing clinical improvement, but no change in mortality rates.

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 22, 2020
Study from China finds that hemophagocytic lymphohistiocytosis (HLH) was a rare (4.2%) but fatal (77.8%) complication in myositis patients (DM, PM, or CADM). Risk factors include baseline Dz activity, worsening ILD and infection https://t.co/QDN1DYzl5p

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 22, 2020
How are you consuming Virtual CME Rheumatology conferences

Dr. John Cush RheumNow ( View Tweet)

Oct 22, 2020
Study from NY shows that Death rates from COVID-19 have dropped (in hospitalized pts) from a high of 27% down to 3%. Partly because a younger, healthier are now getting infected, arriving @ hospital w/ less-severe Sxs.

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 22, 2020
#LTF Listen to Fauci

Dr. John Cush RheumNow ( View Tweet)

Oct 22, 2020
Korea National Health databased looked at Fracture rates in RA patients taking TNFis, abatacept, or tocilizumab betw 2002 to 2016. They found no difference in Fx risk related to the biologic taken. https://t.co/W2dWWseXTc

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 22, 2020
QD Clinic - Triage Rheumatology - Lessons from the clinic. Dr. Jack Cush discusses What constitutes urgent, emergent and Patients you should see https://t.co/0mKvbB9Knv https://t.co/YYN7nOum9t

Links:

Dr. John Cush RheumNow ( View Tweet)
Oct 22, 2020
QD Video - I'm Not Stupid (IgG4) - Lessons from the clinic. Dr. Jack Cush discusses an IgG4 case and the power of discussion https://t.co/RDIVEeyqxW

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 22, 2020
NEW RESEARCH: Abatacept in the treatment of diffuse cutaneous #SystemicSclerosis; clinically meaningful improvements in mRSS and other outcome measures were observed when patients transitioned to open-label #abatacept treatment https://t.co/tDSo3u8hAY #LancetRhe

Links:

The Lancet Rheumatology TheLancetRheum ( View Tweet)
Oct 21, 2020
Congratulations to Dr. Sherine Gabriel on being elected to the National Academy of Medicine - one of the highest honors in medicine. She is president and James A.

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 21, 2020
NEJM reports that obese pts having bariatric surgery have a longer life expectancy (less death HR 0.77; 0.68-0.87; P<0.001) than pts treated w/ nonsurgical, usual obesity care.

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 21, 2020
Empty out your medicine cabinets. Sat Oct 24th is DEA "TAKE BACK" day. Dispose of unused, unwanted, controlled drugs, narcotics, e-cigarettes. Theyll take your tablets, capsules, patches, pens, liquids (BUT NOT syringes, sharps, illegal drugs) Where?

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 21, 2020
Covid lung pneumonia corona

Clinical Trial Boom or Bust in Severe COVID-19

Jack Cush, MD
Oct 20, 2020

A number of recently published clinical trials are further defining the efficacy and outcomes of tocilizumab or remdesivir in treating SARs-CoV-2 infection.



Remdesivir

Read Article
depression oh no HA

Biologic Use for Arthritis Linked With Depression and Anxiety

Jack Cush, MD
Oct 20, 2020

In a recent study of patients with inflammatory rheumatic diseases, the initiation of a biologic treatment or switching to another biologic was associated with an increased likelihood of the use of antidepressants and anxiolytics, reported Petros P. Sfikakis, MD, of the National and Kapodistrian University of Athens, and colleagues in RMD Open: Rheumatic & Musculoskeletal Diseases.

Read Article
Study of seropositivity in RA patients in the RISE (43,581) registry & Marketscan pts (1185) showed ICD10 Coding with M05 had a sensitivity = 0.73- 0.76, & PPV = 0.82 -0.84 for seropositive RA.

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 20, 2020
Swedish population studied CV risk, studied gout. Among 22,057, 910 (4.1%) developed incident gout by 27.5 yrs w/ 5 Clusters: C1 no/few comorb; C2 had CKD; C3 CV dz; C4 obesity, dyslipidemia; C5 DM, HTN, diuretics.

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 20, 2020
Lilly has announced results of Phase 2 SERENITY trial showing the IL-23 inhibitor, mirikizumab, was more effective than PBO at week 12 (PRO and endoscopic outcomes) in moderate to severe active Crohn's disease.

Links:

Dr. John Cush RheumNow ( View Tweet)

Oct 19, 2020
SELECT CHOICE, H2H study of UPA vs ABA in TNF-IR RA pts; UPA had better DAS28-CRP & ABA had better Safety outcomes; Which would you use?

Dr. John Cush RheumNow ( View Tweet)

Oct 19, 2020

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2020 All Rights Reserved.

×